Inactive Instrument
Precision Therapeutics Inc Share Price Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 7.13Cr 6.26Cr 5.82Cr 5.34Cr 10Cr 686.36Cr 10Cr 69Cr 27Cr 337.44Cr 27Cr 26Cr 1.17TCr | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 6.21Cr 5.46Cr 5.08Cr 4.66Cr 8.75Cr 598.48Cr 8.89Cr 60Cr 24Cr 294.23Cr 23Cr 23Cr 1.02TCr | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
93.75% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles L. Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 7.13Cr | ||
| +1.07% | -3.49% | -3.35% | +10.44% | 4.69TCr | ||
| +0.25% | +1.65% | +399.22% | +634.87% | 4.02TCr | ||
| -0.27% | +4.45% | +11.81% | +65.64% | 3.62TCr | ||
| +0.35% | +0.87% | +4.46% | -10.16% | 3.47TCr | ||
| +3.14% | +1.02% | +4.76% | +40.92% | 2.79TCr | ||
| -0.73% | +11.84% | +34.39% | +134.36% | 1.68TCr | ||
| +0.47% | -2.74% | - | - | 1.67TCr | ||
| +0.42% | -5.52% | -3.43% | +9.03% | 1.31TCr | ||
| -2.68% | -2.49% | -11.36% | -33.61% | 1.27TCr | ||
| Average | -0.55% | +0.83% | +54.56% | +106.44% | 2.73TCr | |
| Weighted average by Cap. | +0.48% | +0.91% | +74.42% | +136.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 16.24L 14.26L 13.26L 12.17L 22.87L 16Cr 23.22L 1.57Cr 61.53L 7.69Cr 60.96L 59.64L 27Cr | 1L 1L 1L 93.9T 2L 1.21Cr 2L 12.15L 5L 59.32L 5L 5L 2.05Cr |
| Net income | -1.27Cr -1.11Cr -1.03Cr -94.92L -1.78Cr -121.96Cr -1.81Cr -12Cr -4.8Cr -60Cr -4.75Cr -4.65Cr -207.31Cr | -23Cr -20Cr -19Cr -17Cr -33Cr -2.24TCr -33Cr -226.09Cr -88Cr -1.1TCr -88Cr -86Cr -3.82TCr |
| Net Debt | 13.96L 12.26L 11.41L 10.47L 19.66L 13Cr 19.97L 1.35Cr 52.91L 6.61Cr 52.42L 51.29L 23Cr | -91.25L -80.14L -74.53L -68.39L -1.29Cr -88Cr -1.3Cr -8.85Cr -3.46Cr -43Cr -3.43Cr -3.35Cr -149.37Cr |
Employees
-

















